Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
GMMG-MM5试验中接受治疗的多发性骨髓瘤患者血清游离轻链比值正常化的预后影响
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13194856
Klein, Eva-Maria; Tichy, Diana; Salwender, Hans J; Mai, Elias K; Duerig, Jan; Weisel, Katja C; Benner, Axel; Bertsch, Uta; Akhavanpoor, Mabast; Besemer, Britta; Munder, Markus; Lindemann, Hans-Walter; Hose, Dirk; Seckinger, Anja; Luntz, Steffen; Jauch, Anna; Elmaagacli, Ahmet; Fuhrmann, Stephan; Brossart, Peter; Goerner, Martin; Bernhard, Helga; Raab, Marc S; Blau, Igor W; Haenel, Mathias; Scheid, Christof; Goldschmidt, Hartmut; On Behalf Of The German-Speaking Myeloma Multicenter Group Gmmg